GynTect

Schnell zu einer sicheren Diagnose

Die Neuheit für Diagnostiklabore

GynTect.

GynTect.

Sichere Diagnose

Sie haben Fragen zu GynTect?

Wir helfen weiter!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.

News

If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.

The oncgnostics managers together with Geneo Dx managers and colleagues.

oncgnostics in China: Pitch, Trade Fair, and Meeting with Partner

Dr. Martina Schmitz and Dr. Alfred Hansel, our CSO and CEO, have just come back from a visit in China, with days full of exciting events, dates and a few hours for sightseeing.                 Shenzhen…
Portugal Partnership

Test for Uterine Cancer in Portugal: Biotech Firm oncgnostics Grants Exclusive Licence for Cancer Screening Test

,
Lisbon/Jena, April 16th 2018 – Speculum S.A. is the exclusive licence partner of oncgnostics GmbH for the screening test GynTect® in Portugal. The test is designed to further specify abnormal results in screening examinations and to help…

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Video in German.